Progyny, Inc.
PGNY · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.48 | 0.63 | 0.00 | -1.09 |
| FCF Yield | 2.66% | 2.46% | 3.19% | 2.83% |
| EV / EBITDA | 62.93 | 72.27 | 86.16 | 115.16 |
| Quality | ||||
| ROIC | 2.83% | 2.76% | 2.12% | 1.59% |
| Gross Margin | 23.72% | 23.39% | 21.26% | 20.67% |
| Cash Conversion Ratio | 3.43 | 3.24 | 3.31 | 4.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.09% | 9.06% | 11.59% | 14.04% |
| Free Cash Flow Growth | 6.98% | -6.57% | 17.67% | -23.48% |
| Safety | ||||
| Net Debt / EBITDA | -3.78 | -3.29 | -8.59 | -6.01 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 23.69 | 30.42 | 34.55 | 36.51 |